Paul T. Scott

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also affiliated with University of Pittsburgh, Walter Reed Army Institute of Research

MedicineHealth ProfessionsAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial”.

Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial

The Lancet(2023)10.1016/s0140-6736(22)02400-x

N/A

4.3DataRank · unranked

65 citations

Katherine V. Houser, Amelia R. Hofstetter, Ana M. Ortega‐Villa, Christine Lee, Anne Preston +50 more

SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial

The Lancet Microbe(2024)10.1016/s2666-5247(23)00410-x

N/A

1.3DataRank · unranked

54 citations

Paul T. Scott, Jack N Hutter, Christine U. Lee, Melanie McCauley, Ivelese Guzman +79 more

Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial

The Lancet Infectious Diseases(2023)10.1016/s1473-3099(23)00344-4

N/A

1.0DataRank · unranked

24 citations

Katherine V. Houser, Amelia R. Hofstetter, Ana M. Ortega‐Villa, Prossy Naluyima, Francis Kiweewa +70 more

A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.15.992883

N/A

0DataRank · unranked

52 citations

Rajeshwer S. Sankhala, Wei‐Hung Chen, Misook Choe, Hongjun Bai, Agnes Hajduczki +14 more

Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2106433118

N/A

0DataRank · unranked

67 citations

Michael Joyce, Inès Lakhal-Naouar, Aslaa Ahmed, Camila Macedo Cincotta, Caroline Subra +52 more